M-phase specific PLK1 interacting protein
Dernière mise à jour 6 avr. 2023
Respecte les directives éditoriales
- TéléchargerTélécharger
- Partager
- Language
- Discussion
- Ask Patient
- Version audio
- Ajouter aux sources préférées sur Google
The MPLKIP gene (formerly known as C7orf11) provides instructions for making a protein called M-phase specific PLK1 interacting protein. Based on its interaction with a protein called Plk1, the MPLKIP protein is thought to play a role in cell growth and division. In particular, it may help regulate the cell cycle, which is the cell's way of replicating itself in an organized, step-by-step fashion. The MPLKIP protein also interacts with a protein involved in processing and repairing RNA molecules, which are chemical cousins of DNA.
Sélections vidéo pour GènesBibliothèque vidéo
Normal function
The MPLKIP gene (formerly known as C7orf11) provides instructions for making a protein called M-phase specific PLK1 interacting protein. Based on its interaction with a protein called Plk1, the MPLKIP protein is thought to play a role in cell growth and division. In particular, it may help regulate the cell cycle, which is the cell's way of replicating itself in an organized, step-by-step fashion. The MPLKIP protein also interacts with a protein involved in processing and repairing RNA molecules, which are chemical cousins of DNA.
Conditions referring to this gene or chromosome
Other names
ABHS
C7orf11
chromosome 7 open reading frame 11
ORF20
TTD non-photosensitive 1 protein
TTDN1
TTDN1_HUMAN
Related patient information and medicines

Patient information leaflet
Puis-je prendre Atorvastatine et Mirabegron ensemble ?
Taking these two medicines together may slightly increase the level of atorvastatin in your blood. This could potentially in... Why this happens Mirabegron can slightly interfere with a protein (CYP3A4) and a transporter (P-gp) that the body uses to break down and remove atorvastatin. This means the atorvastatin stays in your system a bit longer.

Patient information leaflet
Régime Dukan
What is the Dukan diet. La Régime Dukan was developed by Pierre Dukan. It is one of the high-protein diets in which both fats and carbohydrates are restricted. This is unlike the Atkins diet Atkins diet , ketogenic diet, and other low-carbohydrate:high-fat (LCHF) diets, in... The Dukan diet consists of four phases designed to aid fast weight loss.

Patient information leaflet
Puis-je prendre le millepertuis et la vitamine D ensemble ?
St John's Wort may lower the levels of Vitamin D in your body, potentially leading to a deficiency. This means your Vitamin D supplement might not work as well as it should to support your bone health and immune system. Why this happens St John's Wort is a 'liver enzyme inducer'. It speeds up the proteins (specifically CYP3A4) in your liver that.

Patient information leaflet
Puis-je prendre Atorvastatine et Levothyroxine ensemble ?
If you significantly change your fibre intake, inform your doctor as ... Using other medicines Taking multiple medicines. Our Vérificateur d'Interactions Médicamenteuses helps you check whether your prescriptions, over-the-counter medicines, et suppléments sont sûr à take together. Simply search for your medicines to see potential interactions and what to do.

Patient information leaflet
Vérifiez vos médicaments pour les interactions
Use this vérificateur d'interactions médicamenteuses to see whether votre medicines, supplements, vitamins, foods, or certain health conditions may interact with each other. It can help you understand potential risks, avoid unwanted side effects, and decide when it’s important to speak to a pharmacist, GP, or other healthcare professional. The tool is.

Patient information leaflet
Régime Atkins
The Atkins diet is a popular weight loss plan based on eating fewer carbohydrates and more fatty foods - low-carbohydrate:high-fat (LCHF) diet. What is the Atkins diet. Dr Robert Atkins was an American heart doctor (cardiologist) who first described the diet. Normally our bodies use glycogen (stored carbohydrate) for energy, but the body uses fat.
Lectures complémentaires et références
- M-phase specific PLK1 interacting protein; MedlinePlus, National Library of Medicine.
- Botta E, Offman J, Nardo T, Ricotti R, Zambruno G, Sansone D, Balestri P, Raams A, Kleijer WJ, Jaspers NG, Sarasin A, Lehmann AR, Stefanini M. Mutations in the C7orf11 (TTDN1) gene in six nonphotosensitive trichothiodystrophy patients: no obvious genotype-phenotype relationships. Hum Mutat. 2007 Jan;28(1):92-6. doi: 10.1002/humu.20419.
- Faghri S, Tamura D, Kraemer KH, Digiovanna JJ. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet. 2008 Oct;45(10):609-21. doi: 10.1136/jmg.2008.058743. Epub 2008 Jun 25.
- Hashimoto S, Egly JM. Trichothiodystrophy view from the molecular basis of DNA repair/transcription factor TFIIH. Hum Mol Genet. 2009 Oct 15;18(R2):R224-30. doi: 10.1093/hmg/ddp390.
- Kraemer KH, Patronas NJ, Schiffmann R, Brooks BP, Tamura D, DiGiovanna JJ. Xeroderma pigmentosum, trichothiodystrophy and Cockayne syndrome: a complex genotype-phenotype relationship. Neuroscience. 2007 Apr 14;145(4):1388-96. doi: 10.1016/j.neuroscience.2006.12.020. Epub 2007 Feb 1.
- Nakabayashi K, Amann D, Ren Y, Saarialho-Kere U, Avidan N, Gentles S, MacDonald JR, Puffenberger EG, Christiano AM, Martinez-Mir A, Salas-Alanis JC, Rizzo R, Vamos E, Raams A, Les C, Seboun E, Jaspers NG, Beckmann JS, Jackson CE, Scherer SW. Identification of C7orf11 (TTDN1) gene mutations and genetic heterogeneity in nonphotosensitive trichothiodystrophy. Am J Hum Genet. 2005 Mar;76(3):510-6. doi: 10.1086/428141. Epub 2005 Jan 11.
- Stefanini M, Botta E, Lanzafame M, Orioli D. Trichothiodystrophy: from basic mechanisms to clinical implications. DNA Repair (Amst). 2010 Jan 2;9(1):2-10. doi: 10.1016/j.dnarep.2009.10.005.
- Zhang Y, Tian Y, Chen Q, Chen D, Zhai Z, Shu HB. TTDN1 is a Plk1-interacting protein involved in maintenance of cell cycle integrity. Cell Mol Life Sci. 2007 Mar;64(5):632-40. doi: 10.1007/s00018-007-6501-8.
Partagez vos pensées ou expériences avec les autres dans notre communautés de patients.
Inscrivez-vous à la newsletter Patient
Votre dose hebdomadaire de conseils de santé clairs et fiables - rédigés pour vous aider à vous sentir informé, confiant et maître de la situation.
En vous abonnant, vous acceptez notre Politique de confidentialité. Vous pouvez vous désabonner à tout moment. Nous ne vendons jamais vos données.

